Insights

Explore how Vizient strengthens supply assurance to combat rising drug shortages and protect patient care through collaboration and innovation... read more

CMS’s 2026 payment changes are shifting wound care to hospital settings, creating opportunities to improve access, cost and care quality... read more

When performance is pieced together from disconnected data, cracks begin to form. Integrated, strategic insights act as your built-to-last blueprint, ensuring healthcare organizations have the struct... read more

At recent Vizient CEO Networks meetings, discussions focused on how structural pressure, chronic disease and AI are converging—and why executive alignment will determine what comes next... read more

A new Vizient Research Institute study examines how chronic disease growth and shifting payer mix are reshaping utilization, margins and patient loyalty, and why health systems must redesign access a... read more

Nurse managers sit at the center of workforce stability, care quality and financial performance. As burnout and turnover threaten health systems, supporting nurse managers has become a critical execu... read more

As care shifts beyond the hospital, health systems must redesign governance, leadership and accountability to unlock ambulatory growth and access... read more

Healthcare enters 2026 under sustained pressure. Explore Vizient’s New margin math report for data-driven insights on costs, workforce, AI, market shifts and financial resilience shaping the year ahe... read more

Margins are tightening and disruption is accelerating. Vizient’s Get ready for a reset report outlines five 2026 healthcare trends and the actions leaders must take now to restore financial sustainab... read more

Ambulatory surgery centers face rising costs and complexity. Learn how supply standardization can reduce variation, strengthen margins and protect quality... read more

For hospitals and health systems, the One Big Beautiful Bill (OBBB) represents both a stress test and an inflection point: a convergence of policy overhaul, payer realignment, workforce turbulence an... read more

With passage of the Inflation Reduction Act, Medicare gained authority to negotiate maximum fair prices for select high-spend, single-source drugs in Parts B and D. This analysis evaluates how wholes... read more